Journal
NEURO-ONCOLOGY
Volume 21, Issue 3, Pages 380-391Publisher
OXFORD UNIV PRESS INC
DOI: 10.1093/neuonc/noy162
Keywords
meningioma; incidence; survival; CBTRUS; SEER
Categories
Funding
- Centers for Disease Control and Prevention (CDC) [2016-M-9030]
- American Brain Tumor Association
- Sontag Foundation
- Novocure
- AbbVie
- Musella Foundation
- National Cancer Institute (NCI) [HHSN261201800176P]
Ask authors/readers for more resources
Meningioma incidence increases significantly with age. In the expanding elderly population, we lack complete understanding of population-based trends in meningioma incidence/survival. We provide an updated, comprehensive analysis of meningioma incidence and survival for individuals aged over 65. Data were obtained from the Central Brain Tumor Registry of the United States (CBTRUS) from 20052015 for nonmalignant and malignant meningioma. Age-adjusted incidence rates per 100000 person-years were analyzed by age, sex, race, ethnicity, location, and treatment modalities. Survival was analyzed using KaplanMeier and multivariable Cox proportional hazards models for a subset of CBTRUS data. Nonmalignant meningioma incidence doubled from adults age 6569 years to adults over age 85 years and was significantly greater in females than males for all ages. Malignant meningioma incidence did not differ by sex for any age grouping. Nonmalignant and malignant meningioma incidence was significantly greater in black populations versus others. Nonmalignant meningioma survival was worse with age, in black populations, and in males, including when analyzed by 5-year age groups. Surgical resection and radiation did not improve survival compared with resection alone in nonmalignant meningioma. This study reports increasing nonmalignant meningioma incidence in the elderly, increased incidence in black populations, and in females. In contrast, malignant meningioma incidence did not differ between sexes. Risk of death was higher for black individuals and males. Additionally, radiation did not confer a survival advantage when combined with resection for nonmalignant meningioma. Thus, we identify clinically relevant discrepancies in meningioma incidence/survival that require further study.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available